Neurocritical Care
Albertson Lab
Asher J. Albertson, MD, PhD
Investigates molecular, neuronal and network mechanisms of stroke injury and recovery, aiming to identify therapeutic targets that improve outcomes after acute brain injury.
Dhar Lab
Rajat Dhar, MD, FRCPC
Focuses on developing advanced neuroimaging techniques to study brain structure and function in neurodegenerative diseases. The lab integrates multimodal imaging, computational modeling and biomarker analysis to understand disease progression and identify early indicators of cognitive decline. Its research aims to improve diagnosis, monitor therapeutic response and uncover mechanisms underlying disorders such as Alzheimer’s disease and related dementias.
Diringer Lab
Michael N. Diringer, MD
Conducting research to improve neurocritical care by studying brain metabolism, blood flow and inflammation in critically ill patients. Using advanced imaging and NIH-supported studies, the lab aims to enhance understanding and treatment of neurological emergencies.
Kang Lab
Peter Kang, MD, MSCI
Advancing a wide spectrum of neurovascular research, the Kang Lab studies small vessel disease, cerebral blood flow and metabolism, ischemic vulnerability and neuroinflammation, while also examining how critical illness shapes cognitive decline and improving neurocritical care through clinical trials, outcomes research, quality initiatives and education.
Kummer Lab
Terrance T. Kummer, MD, PhD
Investigating cellular damage in traumatic brain injury and Alzheimer’s disease. With a focus on synaptic and gray matter injury, the lab uses innovative imaging techniques like SEQUIN to quantify synapse loss and explore its connection to neurodegeneration.